Corcept Therapeutics Inc (NASDAQ: CORT) is -30.79% lower on its value in year-to-date trading and has touched a low of $20.84 and a high of $34.28 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CORT stock was last observed hovering at around $23.00 in the last trading session, with the day’s loss setting it -0.52%.
Currently trading at $22.48, the stock is -7.02% and -5.84% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.09 million and changing -2.26% at the moment leaves the stock -15.40% off its SMA200. CORT registered -0.09% loss for a year compared to 6-month loss of -17.50%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.84% gain in the last 1 month and extending the period to 3 months gives it a -1.71%, and is -2.26% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.86% over the week and 4.10% over the month.
Corcept Therapeutics Inc (CORT) has around 352 employees, a market worth around $2.33B and $482.38M in sales. Current P/E ratio is 23.71 and Fwd P/E is 21.97. Profit margin for the company is 21.87%. Distance from 52-week low is 7.87% and -34.41% from its 52-week high. The company has generated returns on investments over the last 12 months (20.82%).
The EPS is expected to grow by 8.51% this year
The shares outstanding are 103.41M, and float is at 89.19M with Short Float at 23.92%.
Corcept Therapeutics Inc (CORT) Insider Activity
The most recent transaction is an insider sale by Lyon Joseph Douglas, the company’s. SEC filings show that Lyon Joseph Douglas sold 5,443 shares of the company’s common stock on Apr 04 ’24 at a price of $26.00 per share for a total of $0.14 million. Following the sale, the insider now owns 7314.0 shares.
Corcept Therapeutics Inc disclosed in a document filed with the SEC on Apr 01 ’24 that Swisher Daniel N JR (Director) sold a total of 2,200 shares of the company’s common stock. The trade occurred on Apr 01 ’24 and was made at $25.30 per share for $55660.0. Following the transaction, the insider now directly holds 0.0 shares of the CORT stock.
Still, SEC filings show that on Apr 01 ’24, Lyon Joseph Douglas () disposed off 500 shares at an average price of $26.01 for $13004.0. The insider now directly holds 7,314 shares of Corcept Therapeutics Inc (CORT).
